ELIVALDOGENE AUTOTEMCEL
UNII KUM75TD6SG

Substance Identification & Data

This profile provides standardized clinical and technical data for Elivaldogene Autotemcel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KUM75TD6SG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 2612527. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KUM75TD6SG

CAS Registry Number

N/A

RxNorm Concept ID

2612527

Detailed Substance Profile

Preferred Name

ELIVALDOGENE AUTOTEMCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

KUM75TD6SG

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C171808

National Cancer Institute reference terminology for clinical and research data.

INN ID

10901

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-141

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elivaldogene Autotemcel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELIVALDOGENE AUTOTEMCEL

Common Names & Synonyms

ELIVALDOGENE AUTOTEMCEL [INN]

ELIVALDOGENE AUTOTEMCEL [USAN]

ELIVALDOGENE AUTOTEMCEL [WHO-DD]

LENTI-D DRUG SUBSTANCE (CELL THERAPY)

THE CD34+ ENRICHED CELL POPULATION CONTAINING HEMATOPOIETIC STEM AND PROGENITOR CELLS IS OBTAINED FROM AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) COLLECTED BY APHERESIS FROM THE PATIENT FOLLOWING MOBILIZATION OF LEUKOCYTES. THE LENTI-D LVV IS A REPLICATION-DEFECTIVE, SELF-INACTIVATING (SIN), THIRD-GENERATION, LENTIVIRAL VECTOR DERIVED FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE I (HIV-I).